Education
About Us
Working with TipRanks
Follow Us
NeOnc Technologies Holdings, Inc. (NTHI)
NASDAQ:NTHI
NTHI Stock Chart & Stats
$8.36
--
Market closed
$8.36
--
Day’s Range― - ―
52-Week Range$3.20 - $25.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)103.40K
Market Cap
$200.40M
Enterprise Value$68.20M
Total Cash (Recent Filing)$1.51M
Total Debt (Recent Filing)$378.74K
Price to Earnings (P/E)―
Beta1.73
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding23,970,790
10 Day Avg. Volume39,098
30 Day Avg. Volume103,402
Financial Highlights & Ratios
PEG Ratio0.71
Price to Book (P/B)-32.79
Price to Sales (P/S)2174.97
P/FCF Ratio-42.84
Enterprise Value/Market Cap0.34
Enterprise Value/Revenue1.14K
Enterprise Value/Gross Profit1.14K
Enterprise Value/Ebitda-1.28
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
NeOnc Technologies Holdings, Inc. News
NTHI FAQ
What was NeOnc Technologies Holdings, Inc.’s price range in the past 12 months?
NeOnc Technologies Holdings, Inc. lowest stock price was $3.20 and its highest was $25.00 in the past 12 months.
What is NeOnc Technologies Holdings, Inc.’s market cap?
NeOnc Technologies Holdings, Inc.’s market cap is $200.40M.
When is NeOnc Technologies Holdings, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were NeOnc Technologies Holdings, Inc.’s earnings last quarter?
NeOnc Technologies Holdings, Inc. released its earnings results on Aug 19, 2025. The company reported -$0.298 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.298.
Is NeOnc Technologies Holdings, Inc. overvalued?
According to Wall Street analysts NeOnc Technologies Holdings, Inc.’s price is currently Overvalued.
Does NeOnc Technologies Holdings, Inc. pay dividends?
NeOnc Technologies Holdings, Inc. does not currently pay dividends.
What is NeOnc Technologies Holdings, Inc.’s EPS estimate?
NeOnc Technologies Holdings, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NeOnc Technologies Holdings, Inc. have?
NeOnc Technologies Holdings, Inc. has 23,970,790 shares outstanding.
What happened to NeOnc Technologies Holdings, Inc.’s price movement after its last earnings report?
NeOnc Technologies Holdings, Inc. reported an EPS of -$0.298 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -12.335%.
Which hedge fund is a major shareholder of NeOnc Technologies Holdings, Inc.?
Currently, no hedge funds are holding shares in NTHI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
NeOnc Technologies Holdings, Inc. Stock Smart Score
Company Description
NeOnc Technologies Holdings, Inc.
Neonc Technologies Holdings, Inc. develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.
Technical Analysis
Salarius Pharmaceuticals
―
GeoVax Labs
―
GT Biopharma
―
Sensei Biotherapeutics
―
Calidi Biotherapeutics
―
Ownership Overview
64.54% Insiders
0.55% Mutual Funds
5.28% Other Institutional Investors
29.11% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---